Menu
Washingtoner
  • Home
  • Boeing
  • Technology
  • Daryl Guberman
  • Aerospace
  • Health
  • ANSI-ANAB
  • Financial
  • Business
Washingtoner

Ovarian Cancer Research Alliance Joins with Rivkin Center for Ovarian Cancer Research, Strengthening the Fight Against Ovarian Cancer
Washingtoner/10281298

Trending...
  • Acuvance Appoints Sandeep Sabharwal to Board of Directors, Strengthening Leadership to Support Continued Platform Growth
  • Clash of Prompts: The World's First AI Prompt Battle Royale
  • Hazel E Hosts Starline Tours Bus to Sonic Desert - A Launch to Coachella
NEW YORK, Jan. 28, 2025 ~ The Ovarian Cancer Research Alliance (OCRA), the world's largest gynecologic cancer nonprofit, has announced a significant collaboration with the Rivkin Center for Ovarian Cancer Research, effective April 1, 2025. This partnership brings together two highly respected organizations with a shared goal of advancing research for a cure for ovarian cancer.

OCRA will be building upon the Rivkin Center's impressive legacy of funding innovative ovarian cancer research and providing crucial resources to the Pacific Northwest community. This integration will also allow OCRA to expand its reach nationally and globally, ensuring that education, support, and scientific advancements are accessible to the entire ovarian cancer community.

Audra Moran, President and CEO of OCRA, expressed her admiration for the Rivkin Center's contributions in advancing ovarian cancer research and connecting with the community. She believes that this collaboration will create a stronger foundation to support patients and families while honoring Dr. Saul Rivkin's remarkable legacy and driving progress in research.

More on Washingtoner
  • As Fluoride Debate Grips the Nation, Americans Turn to Whole-House Fluoride Filters for Answers
  • FOCUS Hires Carrier-Side Operations Leader to Build the Next Generation of Insurance Service Delivery
  • Adams Security Group LLC Launches New Website to Expand Professional Security Services Across Florida
  • Presidential Acceleration of Psychedelic Therapies Enters a Defining Moment as Federal Policy, FDA Alignment & Breakthrough Neurotechnology Converge
  • Peernovation And Inception Stratos Launch Joint Venture To Build A Global Peer-powered Performance Platform

This announcement comes just one month after The Clearity Foundation joined forces with OCRA, making it the largest organization dedicated to fighting gynecologic cancers in the world. Moran sees these partnerships as a significant step forward in their mission to accelerate research, improve patient care, and create a more cohesive network for those affected by ovarian cancer.

Since its establishment in 1996, the Rivkin Center has been at the forefront of ovarian cancer research. It has provided essential seed-funding grants that have led to groundbreaking discoveries and hosted the biennial Ovarian Cancer Research Symposium in partnership with the American Association of Cancer Research (AACR). Under OCRA's leadership, these signature programs will continue with grants and symposiums renamed to honor Dr. Rivkin's enduring contributions to the field.

Dr. Saul Rivkin, retired oncologist and founder of the Rivkin Center, expressed his confidence in OCRA as an aligned partner to carry forward their vision and amplify their efforts. He believes that this partnership will ensure the growth and success of their investments in research and relationships with the community, bringing them closer to a cure. Dr. Rivkin and his family fully support this exciting new chapter.

More on Washingtoner
  • GDE Tree Services Expands Operations Across Logan, Ipswich and the Gold Coast
  • UK AltNet FullFibre Solves IPv4 Shortage With netElastic BNG And CGNAT Networking Software
  • Tacoma: Applicants Sought for the Equity in Contracting Advisory Committee
  • Tacoma: Hylebos Bridge Closed to Vehicular Traffic
  • Studica Robotics Receives 2026 Partner Excellence Award from FIRST® Robotics Canada

Melissa Rivkin, current board president of the Rivkin Center, will join OCRA's Board of Directors, while Dr. Jackie Lang, director of Scientific Programs at the Rivkin Center, will play a crucial role in OCRA's engagement with the scientific community.

OCRA is committed to continuing beloved Rivkin Center initiatives such as the annual SummeRun for Ovarian Cancer, which will take place on July 13, 2025, in Seattle. Dr. Rivkin will be present at the finish line as always.

More details about the combined programs and services will be shared in the coming months. Both OCRA and the Rivkin Center are dedicated to ensuring a seamless transition that honors the legacy of the Rivkin Center while strengthening support for patients, researchers, and the broader ovarian cancer community.
Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on Washingtoner
  • Tacoma: Statement from District 4 Council Member Sandesh Sadalge on the Critical Importance of Centering Equity in Regional Transit Decisions
  • Seattle Filmmaker Maikaru Launches Mainasty Press with Ambitious "21 Novels in 21 Months" Initiative
  • Tacoma: Street Closure Projected to Start the Week of April 20 for Residential Street Restoration Program Maintenance Work
  • Colorfront Launches New Mac App For Creating Apple Immersive Video
  • Michele Mundy's "Divinely Tailored" Gains Momentum
  • Evermore Bliss Launches AI Wedding Speech Writer to Help Users Create Personalized, Heartfelt Toasts
  • Keenethics enters the ChatGPT Apps ecosystem as a new growth opportunity for businesses
  • Spring Into Your New Home at Heritage at South Brunswick
  • UK Financial Ltd Launches UKFL Premier One as Its Official Broadcast Channel for Premium Content, Podcasts & Independent Expert Analysis
  • The Great Junk Hunt Returns to Its Roots in Puyallup
  • Mayor Anders Ibsen and Council Member Kristina Walker Urge Tacoma Residents to Participate in Sound Transit's Public Survey
  • HarryPotterObamaSonic10Inu (Ticker: BITCOIN) Is the Best Cryptocurrency in Global History
  • Dual-Engine Growth Strategy Unleashed Targeting a $9.1B Market and the Exploding AI Biotech Revolution: KALA BIO (N A S D A Q: KALA)
  • GitKraken Desktop 12.0 Introduces Agent Mode: Gives Developers Ultimate Control & Visualization While Scaling Parallel Agent Workflows
  • 5 Things to Check Before Calling for AC Repair in Philly
  • Go Dental Clinic Announces Upcoming Opening of New Branch in International City, Dubai
  • Hazel E Hosts Starline Tours Bus to Sonic Desert - A Launch to Coachella
  • City Seeks Community Members Interested in Preparing Statements 'For' and 'Against' Proposition 1, the 'Connect Tacoma: Safe Streets and Sidewalks' Ballot Measure
  • Contracting Resources Group and Aalis Management Consulting Launch ARG Joint Venture Under SBA Mentor-Protégé Program
  • Card makers turn to Pink and Main for tools to support their craft
_catLbl0 _catLbl1

Popular on Washingtoner

  • Registered Nurse Launches Healthcare Wealth Strategy Practice for Healthcare Professionals - 638
  • A Letter From the Tacoma City Council to the Sound Transit Board
  • Foiling Freaks Launches New Online Platform Dedicated to Foiling Board Sports
  • Mensa Brings National Board Game Competition to Northern Virginia April 16-19
  • Tacoma: Lincoln Avenue Bridge to Close Saturday, April 18 for Asphalt Repairs
  • Monexplora Explains the Options Mechanics Behind March's Tech Selloff and VIX Surge
  • City Council to Discuss ‘Connect Tacoma’ Transportation Levy Replacement at April 14 Study Session
  • KeysCaribbean Offers 'Skip-the-Crowds' Savings With 15 Percent Off April Stays
  • Spokane: Call for High School Artists: 2026 Riverfront Park Poster Contest
  • Attorney Joseph C. Kreps Files Lawsuit to Stop Alabama State Board of Pharmacy's Unlawful "Revenue-First" Rulemaking

Similar on Washingtoner

  • As Fluoride Debate Grips the Nation, Americans Turn to Whole-House Fluoride Filters for Answers
  • Presidential Acceleration of Psychedelic Therapies Enters a Defining Moment as Federal Policy, FDA Alignment & Breakthrough Neurotechnology Converge
  • Peernovation And Inception Stratos Launch Joint Venture To Build A Global Peer-powered Performance Platform
  • Studica Robotics Receives 2026 Partner Excellence Award from FIRST® Robotics Canada
  • PropAccount.com Adds Equities to Its Multi-Asset Prop Firm Platform, Opening the Door to the World's Largest Trading Market
  • Creator Space LA brings together industry leaders for an immersive AI showcase, demonstrations, and film hackathon
  • Uxur Taxi Unveils Luxury 3,000‑Mile Private Driver Service for Nationwide Travel
  • UK Financial Ltd Launches UKFL Premier One as Its Official Broadcast Channel for Premium Content, Podcasts & Independent Expert Analysis
  • Dual-Engine Growth Strategy Unleashed Targeting a $9.1B Market and the Exploding AI Biotech Revolution: KALA BIO (N A S D A Q: KALA)
  • Revenue Optics Completes Full Commercial Buildout. A Nine-Month-Old Firm Built on 25 Years of Distribution Expertise. Five Clients From $200M to $3B
Copyright © 2026 washingtoner.com | Terms of Service | Privacy Policy | Contact Us | Contribute